Strategies of Influence: How Corporate Power Directs and Constrains the FDA
Solet, David M.
MetadataShow full item record
CitationStrategies of Influence: How Corporate Power Directs and Constrains the FDA (2001 Third Year Paper)
AbstractThis paper is about the Food and Drug Administration, and the tactics that regulated â€“ and sometimes unregulated â€“ industries use to influence that agencyâ€™s decision-making process. Many of these tactics are legal; others are illegal, but difficult to recognize and police. In virtually every case, the purpose of these tactics is to undermine the neutral and detached scientific processes to which the FDA aspires, in order to advance the financial interests of regulated industries. While some of the details recounted herein are gravely disturbing, even outrageous, the purpose of this paper is not to moralize, but to identify these tactics and assess them in a neutral fashion, in order that they may offer some lesson about the systemic structures that created them
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8846804
- HLS Student Papers